GlassScriptPhysician profile
David Sandberg
NPI 1336157239
$5,179.42
in general payments reported to CMS, 2019-2025
41 companies · $1,123 in 2025
The $1,123 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $410 · 2021: $726 · 2022: $884 · 2023: $632 · 2024: $996 · 2025: $1,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,750.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,307.34 | 2019-2025 | Grafix Pl, Stravix Pl, Stravix |
| Stryker Corporation | $477.89 | 2019-2025 | Hoffmann, Easyfuse, Prostep |
| Organogenesis INC. | $384.08 | 2021-2022 | |
| Musculoskeletal Transplant Foundation INC. | $244.41 | 2019-2020 | |
| Abbvie INC. | $225.58 | 2021-2025 | Dalvance |
| Horizon Therapeutics Plc | $203.56 | 2019-2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $201.14 | 2025 | Tapestry, Subchondroplasty Knee Kit |
| Silk Road Medical, INC. | $119.31 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Convatec INC. | $116.76 | 2021-2023 | |
| Smoky Mountain Surgical LLC | $99.44 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $90.89 | 2022-2025 | Nuzyra |
| Melinta Therapeutics, LLC | $63.23 | 2019 | |
| Grt US Holding, INC. | $46.87 | 2022 | |
| Allergan, INC. | $45.58 | 2020 | |
| Bioventus LLC | $35.87 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Triad Life Sciences INC. | $35.24 | 2021 | |
| Amgen INC. | $33.38 | 2025 | Krystexxa |
| Kerecis Limited | $32.21 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ossur Americas, INC. | $28.14 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $27.63 | 2022-2023 | Seglentis |
| Zyla Life Sciences, INC. | $27.21 | 2019 | |
| Medartis INC. | $24.98 | 2019 | |
| Acera Surgical, INC. | $24.79 | 2025 | Restrata Wound Matrix |
| Reprise Biomedical, INC. | $22.50 | 2025 | Miro3d |
| Advanced Oxygen Therapy INC. | $22.21 | 2025 | Topical Oxygen Chamber For Extremities |
| Ethicon US, LLC | $21.03 | 2024 | Dermabond Prineo, Stratafix |
| Aroa Biosurgery Incorporated | $18.83 | 2019 | |
| Integra Lifesciences Corporation | $18.81 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Nevro Corp. | $18.63 | 2023 | Senza |
| Vertex Pharmaceuticals Incorporated | $18.08 | 2025 | |
| Solventum Corporation | $17.47 | 2025 | Activ.A.C. |
| Medline Industries LP | $16.32 | 2025 | |
| Arteriocyte Medical Systems, INC. | $16.23 | 2023 | Magellan |
| Sanara Medtech INC. | $14.28 | 2024 | Celleraterx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.11 | 2020 | |
| Assertio Therapeutics, INC. | $13.08 | 2019 | |
| Hartmann USA, INC. | $12.57 | 2021 | |
| Trice Medical, INC. | $12.52 | 2025 | |
| Merck Sharp & Dohme LLC | $12.21 | 2019 | |
| Cardiovascular Systems INC. | $8.65 | 2020 | |
| Orthofix Medical, INC. | $6.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sandberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.